I received my Ph.D. in molecular and cellular biology from Berkeley. Following this I worked in food biotechnology regulation at the US FDA. I then moved to regulatory strategy at Wyeth where I worked in autoimmune disease, tissue repair, and other areas. After the merger with Pfizer I was responsible for regulatory strategy for Pfizer R&D. I am currently VP of regulatory strategy for Inflammation and Immunology at Pfizer R and D. I have 25 years of regulatory experience.